MedTrace Logo

Interactions Between Antiretrovirals (ARVs) and Combined Oral Contraceptives (COCs)

NCT00829114 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 370

Last updated 2011-10-31

No results posted yet for this study

Summary

Non-randomized, comparative study (1:1 allocation) to study interactions between nevirapine-containing antiretroviral therapies and combined oral contraceptive pills.

Conditions

Interventions

DRUG

ETHINYL ESTRADIOL AND LEVOGESTREL

30 MCG OF ETHINYL ESTRADIOL AND 150 MCG LEVOGESTREL

DRUG

ETHINYL ESTRADIOL AND LEVOGESTREL

30 MCG OF ETHINYL ESTRADIOL AND 150 MCG LEVOGESTREL

Sponsors & Collaborators

  • United States Agency for International Development (USAID)

    collaborator FED

  • Makerere University

    collaborator OTHER

  • RHRU National Office, University of Witwatersand, Johannesburg

    collaborator UNKNOWN

  • FHI 360

    lead OTHER

Principal Investigators

  • Kavita Nanda, MD · FHI 360

  • Vera Halpern, MD · FHI 360

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • South Africa
  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00829114 on ClinicalTrials.gov